Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Department of Justice
Deloitte
Medtronic
Mallinckrodt
Merck
Fuji
Boehringer Ingelheim
Baxter

Generated: April 26, 2018

DrugPatentWatch Database Preview

ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE Drug Profile

« Back to Dashboard

When do Acetaminophen, Caffeine And Dihydrocodeine Bitartrate patents expire, and when can generic versions of Acetaminophen, Caffeine And Dihydrocodeine Bitartrate launch?

Acetaminophen, Caffeine And Dihydrocodeine Bitartrate is a drug marketed by Larken Labs Inc and is included in one NDA.

The generic ingredient in ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
Summary for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE
Drug patent expirations by year for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE
Pharmacology for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE

US Patents and Regulatory Information for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Larken Labs Inc ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE acetaminophen; caffeine; dihydrocodeine bitartrate TABLET;ORAL 204209-001 Sep 30, 2016 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Deloitte
Cipla
McKesson
Mallinckrodt
Merck
Boehringer Ingelheim
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.